You are here

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
545 A phase 2 study of retifanlimab in patients with advanced or metastatic merkel cell carcinoma (MCC) (POD1UM-201)
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to March 2024

AbstractFullPdf
Nov 2021346014
Dec 20217408
Jan 2022122012
Feb 2022154017
Mar 2022228015
Apr 2022120018
May 202290021
Jun 202232015
Jul 202244012
Aug 20227205
Sep 2022112036
Oct 202296010
Nov 2022112021
Dec 20226808
Jan 2023124015
Feb 20239008
Mar 2023520054
Apr 2023678078
May 2023482068
Jun 2023248054
Jul 2023240043
Aug 2023249037
Sep 2023252037
Oct 2023324062
Nov 2023246051
Dec 2023264036
Jan 2024108013
Feb 2024226022
Mar 2024294038
Total60150828